Share
Journal Information
Most often read
16432
Gut microbiota and type 2 diabetes mellitusAraceli Muñoz-Garach, Cristina Diaz-Perdigones, Francisco J. Tinahones
Endocrinol Nutr. 2016;63:560-8
16432
Full text access
16187
Impact of obesity on bone metabolismJuan J. López-Gómez, José L. Pérez Castrillón, Daniel A. de Luis Román
Endocrinol Nutr. 2016;63:551-9
16187
Full text access
11800
Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitusIrene Romera, Francisco Javier Ampudia-Blasco, Antonio Pérez, Bernat Ariño, Egon Pfarr, Sanja Giljanovic Kis, Ebrahim Naderali
Endocrinol Nutr. 2016;63:519-26
11800
Full text access
11682
Venlafaxine drug interaction in the diagnosis of pheochromocytomaAna Belén Mañas-Martínez, Alicia Aragoneses-Calvo, Ana Matei, Sylvie Ojeda-Rodríguez, Pilar García-Durruti
Endocrinol Nutr. 2016;63:569-70
11682
Full text access
9914
Impact of diabetes education on type 1 diabetes mellitus control in childrenDaniel E. Alonso Martín, M. Belén Roldán Martín, M. Ángeles Álvarez Gómez, Rosa Yelmo Valverde, María Martín-Frías, Milagros Alonso Blanco, Raquel Barrio Castellanos
Endocrinol Nutr. 2016;63:536-42
9914
Full text access
9067
Endocrinology, diabetes and nutrition: The future is hereDídac Mauricio, Ignacio Conget, Edelmiro Menéndez, Manuel Puig-Domingo
Endocrinol Nutr. 2016;63:509-10
9067
Full text access
6635
Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)Roberto Nuño-Solinís, Edurne Alonso-Morán, Jose M. Arteagoitia Axpe, Patxi Ezkurra Loiola, Juan F. Orueta, Sonia Gaztambide
Endocrinol Nutr. 2016;63:543-50
6635
Full text access
5548
Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitusAntoni Sicras-Mainar, Ruth Navarro-Artieda, Raúl Morano, Lucía Ruíz
Endocrinol Nutr. 2016;63:527-35
5548
Full text access
4957
Cardiovascular risk factors in scholars (RIVACANGAS)Rocío Mera-Gallego, Patricia García-Rodríguez, Marta Fernández-Cordeiro, Ángeles Rodríguez-Reneda, Natalia Vérez-Cotelo, N. Floro Andrés-Rodríguez, J. Antonio Fornos-Pérez, Itxaso Rica-Echevarría
Endocrinol Nutr. 2016;63:511-8
4957
Full text access
4532
Bariatric surgery results in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion therapyJesus Moreno-Fernandez, Ana Chico
Endocrinol Nutr. 2016;63:571-2
4532
Full text access
3272
Statement on the current treatment of severe obesity in SpainFelipe Casanueva, Felipe de la Cruz Vigo, Albert Goday, Juan Carlos Ruiz de Adana, Susana Monereo, Ramón Vilallonga, Purificación Martínez de Icaya, Raquel Sánchez-Santos, ... Ismael Díez del Val
Endocrinol Nutr. 2016;63:573-4
3272
Full text access
Special content about COVID-19
- Gut microbiota and type 2 diabetes mellitus
- Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
- Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
- Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Publication History